Relationship of arachidonic acid release to porcine coronary artery relaxation

Neal Lee Weintraub, A. H. Stephenson, R. S. Sprague, L. McMurdo, A. J. Lonigro

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In porcine coronary artery endothelium-dependent relaxation to bradykinin is in part attributed to a chemically unidentified factor, termed endothelium-derived hyperpolarizing factor (EDHF). We hypothesize that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production. To define the relationship between EDHF production and arachidonic acid release we investigated the role of phospholipase C in bradykinin-induced relaxation and prostaglandin I2 production (an index of arachidonic acid release) in porcine coronary artery. The phospholipase C inhibitor U73122 (1 μmol L) abolished bradykinin- induced, nitric oxide-mediated relaxation but did not inhibit either bradykinin-induced, EDHF-mediated relaxation or prostaglandin I2 production. However, when given at a larger dose (20 μmol) U73122 abolished both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Similarly, the calcium-ATPase inhibitor thapsigargin, given at a dose (1 μmol/L) that abolished bradykinin-induced increase in intracellular calcium concentration in cultured porcine coronary artery endothelial cells, eliminated both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Although thapsigargin abolished bradykinin- induced prostaglandin I2 production, the basal production of prostaglandin I2 was enhanced, and contraction of endothelium-intact rings was attenuated. These latter responses are most likely related to enhanced basal arachidonic acid release and associated EDHF production. These observations suggest that phospholipase C activation and increased intracellular calcium concentration are required for both bradykinin-induced arachidonic acid release and EDHF production in porcine coronary artery. Moreover, EDHF production in porcine coronary artery appears to the closely associated with arachidonic acid release, thus supporting the hypothesis that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production in porcine coronary artery.

Original languageEnglish (US)
Pages (from-to)684-690
Number of pages7
JournalHypertension
Volume26
Issue number4
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Arachidonic Acid
Endothelium
Coronary Vessels
Bradykinin
Swine
Epoprostenol
Type C Phospholipases
Thapsigargin
Prostaglandin-Endoperoxide Synthases
Calcium
Calcium-Transporting ATPases
Nitric Oxide
Endothelial Cells

Keywords

  • arachidonic acid
  • arteries
  • endothelium-derived factors
  • epoprostenol
  • nitric oxide
  • phospholipase C
  • phospholipases A

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Relationship of arachidonic acid release to porcine coronary artery relaxation. / Weintraub, Neal Lee; Stephenson, A. H.; Sprague, R. S.; McMurdo, L.; Lonigro, A. J.

In: Hypertension, Vol. 26, No. 4, 01.01.1995, p. 684-690.

Research output: Contribution to journalArticle

Weintraub, NL, Stephenson, AH, Sprague, RS, McMurdo, L & Lonigro, AJ 1995, 'Relationship of arachidonic acid release to porcine coronary artery relaxation', Hypertension, vol. 26, no. 4, pp. 684-690. https://doi.org/10.1161/01.HYP.26.4.684
Weintraub, Neal Lee ; Stephenson, A. H. ; Sprague, R. S. ; McMurdo, L. ; Lonigro, A. J. / Relationship of arachidonic acid release to porcine coronary artery relaxation. In: Hypertension. 1995 ; Vol. 26, No. 4. pp. 684-690.
@article{4378114eb4aa4dffb974f4530b804287,
title = "Relationship of arachidonic acid release to porcine coronary artery relaxation",
abstract = "In porcine coronary artery endothelium-dependent relaxation to bradykinin is in part attributed to a chemically unidentified factor, termed endothelium-derived hyperpolarizing factor (EDHF). We hypothesize that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production. To define the relationship between EDHF production and arachidonic acid release we investigated the role of phospholipase C in bradykinin-induced relaxation and prostaglandin I2 production (an index of arachidonic acid release) in porcine coronary artery. The phospholipase C inhibitor U73122 (1 μmol L) abolished bradykinin- induced, nitric oxide-mediated relaxation but did not inhibit either bradykinin-induced, EDHF-mediated relaxation or prostaglandin I2 production. However, when given at a larger dose (20 μmol) U73122 abolished both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Similarly, the calcium-ATPase inhibitor thapsigargin, given at a dose (1 μmol/L) that abolished bradykinin-induced increase in intracellular calcium concentration in cultured porcine coronary artery endothelial cells, eliminated both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Although thapsigargin abolished bradykinin- induced prostaglandin I2 production, the basal production of prostaglandin I2 was enhanced, and contraction of endothelium-intact rings was attenuated. These latter responses are most likely related to enhanced basal arachidonic acid release and associated EDHF production. These observations suggest that phospholipase C activation and increased intracellular calcium concentration are required for both bradykinin-induced arachidonic acid release and EDHF production in porcine coronary artery. Moreover, EDHF production in porcine coronary artery appears to the closely associated with arachidonic acid release, thus supporting the hypothesis that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production in porcine coronary artery.",
keywords = "arachidonic acid, arteries, endothelium-derived factors, epoprostenol, nitric oxide, phospholipase C, phospholipases A",
author = "Weintraub, {Neal Lee} and Stephenson, {A. H.} and Sprague, {R. S.} and L. McMurdo and Lonigro, {A. J.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1161/01.HYP.26.4.684",
language = "English (US)",
volume = "26",
pages = "684--690",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Relationship of arachidonic acid release to porcine coronary artery relaxation

AU - Weintraub, Neal Lee

AU - Stephenson, A. H.

AU - Sprague, R. S.

AU - McMurdo, L.

AU - Lonigro, A. J.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - In porcine coronary artery endothelium-dependent relaxation to bradykinin is in part attributed to a chemically unidentified factor, termed endothelium-derived hyperpolarizing factor (EDHF). We hypothesize that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production. To define the relationship between EDHF production and arachidonic acid release we investigated the role of phospholipase C in bradykinin-induced relaxation and prostaglandin I2 production (an index of arachidonic acid release) in porcine coronary artery. The phospholipase C inhibitor U73122 (1 μmol L) abolished bradykinin- induced, nitric oxide-mediated relaxation but did not inhibit either bradykinin-induced, EDHF-mediated relaxation or prostaglandin I2 production. However, when given at a larger dose (20 μmol) U73122 abolished both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Similarly, the calcium-ATPase inhibitor thapsigargin, given at a dose (1 μmol/L) that abolished bradykinin-induced increase in intracellular calcium concentration in cultured porcine coronary artery endothelial cells, eliminated both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Although thapsigargin abolished bradykinin- induced prostaglandin I2 production, the basal production of prostaglandin I2 was enhanced, and contraction of endothelium-intact rings was attenuated. These latter responses are most likely related to enhanced basal arachidonic acid release and associated EDHF production. These observations suggest that phospholipase C activation and increased intracellular calcium concentration are required for both bradykinin-induced arachidonic acid release and EDHF production in porcine coronary artery. Moreover, EDHF production in porcine coronary artery appears to the closely associated with arachidonic acid release, thus supporting the hypothesis that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production in porcine coronary artery.

AB - In porcine coronary artery endothelium-dependent relaxation to bradykinin is in part attributed to a chemically unidentified factor, termed endothelium-derived hyperpolarizing factor (EDHF). We hypothesize that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production. To define the relationship between EDHF production and arachidonic acid release we investigated the role of phospholipase C in bradykinin-induced relaxation and prostaglandin I2 production (an index of arachidonic acid release) in porcine coronary artery. The phospholipase C inhibitor U73122 (1 μmol L) abolished bradykinin- induced, nitric oxide-mediated relaxation but did not inhibit either bradykinin-induced, EDHF-mediated relaxation or prostaglandin I2 production. However, when given at a larger dose (20 μmol) U73122 abolished both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Similarly, the calcium-ATPase inhibitor thapsigargin, given at a dose (1 μmol/L) that abolished bradykinin-induced increase in intracellular calcium concentration in cultured porcine coronary artery endothelial cells, eliminated both bradykinin-induced. EDHF-mediated relaxation and prostaglandin I2 production. Although thapsigargin abolished bradykinin- induced prostaglandin I2 production, the basal production of prostaglandin I2 was enhanced, and contraction of endothelium-intact rings was attenuated. These latter responses are most likely related to enhanced basal arachidonic acid release and associated EDHF production. These observations suggest that phospholipase C activation and increased intracellular calcium concentration are required for both bradykinin-induced arachidonic acid release and EDHF production in porcine coronary artery. Moreover, EDHF production in porcine coronary artery appears to the closely associated with arachidonic acid release, thus supporting the hypothesis that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production in porcine coronary artery.

KW - arachidonic acid

KW - arteries

KW - endothelium-derived factors

KW - epoprostenol

KW - nitric oxide

KW - phospholipase C

KW - phospholipases A

UR - http://www.scopus.com/inward/record.url?scp=0029100174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029100174&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.26.4.684

DO - 10.1161/01.HYP.26.4.684

M3 - Article

VL - 26

SP - 684

EP - 690

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -